Tag Archives: Zelda Therapeutics

Zelda Announces Priority Share Offer for CannPal Animal Therapeutics IPO Shares

Zelda Joins with US Children’s Hospital to Study Cannabinoid Treatment in Autism

Zelda Joins with US Children’s Hospital to Study Cannabinoid Treatment in Autism

PERTH, Australia, Dec. 11, 2017 /Weed Wire/ — The Board of Zelda Therapeutics Ltd (ASX: ZLD, Zelda or the Company) is pleased to announce it has entered into a research agreement with Children’s Hospital of Philadelphia (CHOP) to study the pharmacology of cannabinoids.

Zelda Announces Priority Share Offer for CannPal Animal Therapeutics IPO Shares

Zelda Announces Priority Share Offer for CannPal Animal Therapeutics IPO Shares

The Board of Zelda Therapeutics Ltd is pleased to announce that its shareholders are invited to participate as a priority applicant in the prospectus capital raising of CannPal Animal Therapeutics Limited (CannPal) lodged with the ASIC.

Zelda Therapeutics Research Programme Zelda autism Research Collaboration

Zelda Expands Its Breast Cancer Research Collaboration with Complutense University Madrid

PERTH, Australia, July 31, 2017 /Weed Wire/ — The Board of Zelda Therapeutics Ltd (ASX: ZLD, Zelda or the Company) is pleased to announce it has expanded its research collaboration with Complutense University.

Why these pot stocks smoked the ASX today

Why These Pot Stocks Smoked the ASX Today

It certainly has been a great day for pot stocks on the ASX. This morning Federal Health Minister Greg Hunt announced that the government would allow medical marijuana companies to distribute cannabis oils and medications in Australia within the next couple of months.


Top